ES8407039A1 - Un procedimiento para preparacion de una quinalozina. - Google Patents

Un procedimiento para preparacion de una quinalozina.

Info

Publication number
ES8407039A1
ES8407039A1 ES522278A ES522278A ES8407039A1 ES 8407039 A1 ES8407039 A1 ES 8407039A1 ES 522278 A ES522278 A ES 522278A ES 522278 A ES522278 A ES 522278A ES 8407039 A1 ES8407039 A1 ES 8407039A1
Authority
ES
Spain
Prior art keywords
quinazoline
cardiac stimulants
stimulants
cardiac
sulfonamidoalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522278A
Other languages
English (en)
Other versions
ES522278A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp
Original Assignee
Pfizer Corp Belgium
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp filed Critical Pfizer Corp Belgium
Publication of ES8407039A1 publication Critical patent/ES8407039A1/es
Publication of ES522278A0 publication Critical patent/ES522278A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UNA QUINAZOLINA.CONSISTE EN HACER REACCIONAR UNA QUINAZOLINA DE FORMULA (II) CON UNA PIPERIDINA DE FORMULA (III), O CON UNA SAL DE ADICION DE ACIDO DE LA MISMA, Y POSTERIOR ALQUILACION, REDUCCION SELECTIVA O CONVERSION, EN UNA SAL FARMACEUTICAMENTE ACEPTABLE, PARA OBTENER QUINAZOLINA DE FORMULA (I), DONDE X ES UN GRUPO ALQUILENO DE CADENA LINEAL O RAMIFICADA CON C 1 A 4; Y ES UN GRUPO DE FORMULA (IV); R1 ES H O ALQUILO C 1 A 4; R Y R SON H O CH3.TIENEN APLICACION FARMACEUTICA POR SER ESTIMULANTES CARDIACOS.
ES522278A 1982-05-15 1983-05-11 Un procedimiento para preparacion de una quinalozina. Granted ES522278A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8214206 1982-05-15

Publications (2)

Publication Number Publication Date
ES8407039A1 true ES8407039A1 (es) 1984-08-16
ES522278A0 ES522278A0 (es) 1984-08-16

Family

ID=10530384

Family Applications (3)

Application Number Title Priority Date Filing Date
ES522278A Granted ES522278A0 (es) 1982-05-15 1983-05-11 Un procedimiento para preparacion de una quinalozina.
ES528482A Granted ES528482A0 (es) 1982-05-15 1983-12-28 Un procedimiento para la preparacion de una quinazolina
ES528481A Expired ES8504793A1 (es) 1982-05-15 1983-12-28 Un procedimiento para la preparacion de una quinazolina

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES528482A Granted ES528482A0 (es) 1982-05-15 1983-12-28 Un procedimiento para la preparacion de una quinazolina
ES528481A Expired ES8504793A1 (es) 1982-05-15 1983-12-28 Un procedimiento para la preparacion de una quinazolina

Country Status (22)

Country Link
US (1) US4489075A (es)
EP (1) EP0094766B1 (es)
JP (1) JPS58208289A (es)
KR (1) KR840004747A (es)
AU (1) AU538171B2 (es)
CA (1) CA1195977A (es)
DD (2) DD216018A5 (es)
DE (1) DE3368631D1 (es)
DK (1) DK210183A (es)
ES (3) ES522278A0 (es)
FI (1) FI831684L (es)
GR (1) GR77498B (es)
IL (1) IL68668A0 (es)
IN (1) IN160680B (es)
NO (1) NO831728L (es)
NZ (1) NZ204225A (es)
PH (1) PH18763A (es)
PL (2) PL241968A1 (es)
PT (1) PT76687B (es)
SU (1) SU1194257A3 (es)
YU (1) YU105083A (es)
ZA (1) ZA833422B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
US5138062A (en) * 1989-10-03 1992-08-11 Philip Morris Incorporated Nicotine analogs
CZ289756B6 (cs) * 1991-03-28 2002-04-17 Eisai Co., Ltd. Heterocyklicko-cyklické aminové deriváty, meziprodukty postupu přípravy těchto sloučenin, farmaceutický prostředek a pouľití uvedených derivátů
US9920043B2 (en) * 2014-05-15 2018-03-20 Pfizer Inc. Crystalline form of 6-[(4R)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl]iosoquinoline-1-carbonitrile

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971783A (en) * 1973-03-07 1976-07-27 Pfizer Inc. 4-Aminoquinazoline derivatives as cardiac stimulants
GB1460389A (en) * 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants
US4171363A (en) * 1977-02-22 1979-10-16 Bristol-Myers Company 1,2,3-Thiadiazole process
CA1086735A (en) * 1977-11-03 1980-09-30 John C. Danilewicz Piperidino-quinazolines

Also Published As

Publication number Publication date
NO831728L (no) 1983-11-16
NZ204225A (en) 1985-12-13
PL241968A1 (en) 1984-08-13
IL68668A0 (en) 1983-09-30
DE3368631D1 (de) 1987-02-05
IN160680B (es) 1987-07-25
ES528481A0 (es) 1985-05-01
ZA833422B (en) 1984-02-29
ES8504794A1 (es) 1985-05-01
EP0094766A3 (en) 1984-12-12
CA1195977A (en) 1985-10-29
SU1194257A3 (ru) 1985-11-23
EP0094766A2 (en) 1983-11-23
KR840004747A (ko) 1984-10-24
PL247054A1 (en) 1985-03-26
AU1452283A (en) 1983-11-17
PH18763A (en) 1985-09-20
YU105083A (en) 1986-02-28
DK210183D0 (da) 1983-05-11
DK210183A (da) 1983-11-16
FI831684L (fi) 1983-11-16
EP0094766B1 (en) 1986-12-30
DD210269A5 (de) 1984-06-06
GR77498B (es) 1984-09-24
FI831684A0 (fi) 1983-05-13
ES528482A0 (es) 1985-05-01
US4489075A (en) 1984-12-18
AU538171B2 (en) 1984-08-02
ES8504793A1 (es) 1985-05-01
PT76687A (en) 1983-06-01
DD216018A5 (de) 1984-11-28
JPS58208289A (ja) 1983-12-03
ES522278A0 (es) 1984-08-16
PT76687B (en) 1986-03-27

Similar Documents

Publication Publication Date Title
DE3584172D1 (de) 17-beta-substituierte-4-aza-5-alpha-androstenone und ihre anwendung als 5-alpha-reduktase-inhibitoren.
DE3788292D1 (de) Verwendung von Tetrathiafulvalenen in bioelectrochemischen Verfahren.
ES8606289A1 (es) Un procedimiento para la preparacion de piridazinaminas.
ZA806788B (en) 4-(5(and 4)-subsittuted-2-thienyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic and oxidase
UA5953A1 (uk) Спосіб отримання похідних сульфонілмочевин
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
ES8304967A1 (es) Un procedimiento para la preparacion de una n-(2-pirimidinil) piperazinilalquilazaespiroalcanodiona.
DE69016178D1 (de) Zusammensetzung von Nachlaufherbiziden, die Silikonglycole mit Acetoxyendgruppen sowie Dispergiermittel enthalten.
DE68913397D1 (de) Verwendung von 5-heteroaryl- oder 5-arylsubstituierten Imidazo(2,1-a)isochinolinen.
DE3673217D1 (de) Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
IT8419730A0 (it) Procedimento per la trasformazione quantitativa di teicoplanina a2fattore 1 in teicoplanina a2fattore 3.
EP0398084A3 (en) Nitro-substituted heterocyclic compounds
ES8504794A1 (es) Un procedimiento para la preparacion de una quinazolina
ATE51229T1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
IE810767L (en) Prepartion of 2, 2, 6, 6-tetramethylpiperidone-4.
EP0149588A3 (en) N-(naphthyl-alkyl)-hydroxylamines
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
TR21858A (tr) Yeni 2-siyano-imidazopiridin tuerevleri bunlarin hazirlanmasi ve bunlarin fungusid olarak kullanilmasi
AU561309B2 (en) Diarylindane-1,3-diones
JPS56131578A (en) Novel derivative of 2-piperidino-4-amino-6,7- dimethoxyquinazoline and its manufacture
DE3882545D1 (de) Verwendung von trifluormethansulfonamid gegen glaukom.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
FR2517679B1 (es)
DE3779211D1 (de) Verwendung von dihydrobenzopyranderivaten.